IN-VITRO COMPARATIVE QUALITY EVALUATION OF DIFFERENT BRANDS OF RANOLAZINE TABLETS MARKETED IN ANDHRA PRADESH, INDIA

Authors

  • SHANNU SHAIK Department of Pharmaceutical Analysis, Vignan Pharmacy College, Andhra Pradesh, India.
  • BUTHUKURI LAKSHMI PRASANNA Department of Pharmaceutical Analysis, Vignan Pharmacy College, Andhra Pradesh, India.
  • PRATHIKANTAM THARUN KUMAR Department of Pharmaceutical Analysis, Vignan Pharmacy College, Andhra Pradesh, India.
  • SHAIK AFRIN Department of Pharmaceutical Analysis, Vignan Pharmacy College, Andhra Pradesh, India.
  • SIVA KRISHNA PUSULURI Department of Pharmaceutical Analysis, Vignan Pharmacy College, Andhra Pradesh, India.
  • SRINIVASA BABU PUTTAGUNTA Department of Pharmaceutics, Vignan Pharmacy College, Andhra Pradesh, India.
  • MUNNANGI MUKKANTI ESWARUDU Department of Pharmaceutical Analysis, Vignan Pharmacy College, Andhra Pradesh, India.

Keywords:

Ranolazine hydrochloride, drug quality, hardness, friability, disintegration, drug release

Abstract

An extended-release tablet provides prolonged periods of drug in plasma levels thereby reduce dosing frequency, improve patient compliance and reduce the dose-related side effects. Ranolazine is indicated for the chronic treatment of angina in patients who have not achieved an adequate response with other anti-anginal agents. In this study, an attempt was made to investigate the in-vitro quality control testing of five different prominent pharmaceutical brands of Ranolazine hydrochloride tablets marketed in Andhra Pradesh, India. Five different brands of tablets used in the study, named brand A, brand B, brand C, brand D, and brand E were evaluated for weight variation, content uniformity, thickness, hardness, disintegration, dissolution, and assay. The study utilized standardized testing methods to ensure consistency and reliability across all assessments. Results revealed that all the brands of Ranolazine tablets complied with the official specification for hardness, friability, disintegration and assay. All the selected brands of Ranolazine tablets complied with the USP dissolution tolerance limits, the tablets demonstrated robust mechanical strength, minimal friability, and prompt disintegration of active pharmaceutical ingredients.

References

Abbas, H.K., Hameed, H.M., Jawad, K.A., Jabur, M.N., Zuhear, S.M., Kadhim, A.B., Kadhim, M.K. (2023): In-vitro comparative quality evaluation of paracetamol tablets marketed in Iraq. – Journal of Medicinal and Chemical Sciences 6(5): 1087-1099.

Alexandar, S., Kumar, M., Kumudhavalli, M.V., Umamaheswari, D., Jaykar, B. (2017): Formulation and evaluation of buoyant type of gastro retentive dosage forms of ranolazine tablets. – Journal of Pharmaceutical Sciences and Research 9(2): 145-149.

Asaduzzaman, M., Rahman, M.R., Khan, M.S.R., Islam, S.A. (2011): Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: in vitro drug release and kinetic approach. – Journal of Applied Pharmaceutical Science 1(8): 131-136.

Bidada, J., Gonjari, I., Bhusari, A., Raut, C., Dhule, A. (2011): Development of extended release matrix tablets of ranolazine containing polyacrylic and ethylcellulose polymers. – Der Pharmacia Lettre 3(4): 215-226.

Doppa, D.V.S., Konidala, S.K., Khanabhi, S. (2019): Development and validation of UV spectroscopic method for the determination of ranolazine in bulk and formulation. – Research Journal of Pharmacy and Technology 12(10): 5007-5010.

Gunda, R.K., Manchineni, P.R., Duraiswamy, D., Gsn, K.R. (2022): Design, development, optimization and evaluation of ranolazine extended release tablets. – Turkish Journal of Pharmaceutical Sciences 19(2): 125-131.

Immel, B. (2013): Quality Assurance of Pharmaceuticals. – In Encyclopedia of Pharmaceutical Science and Technology, CRC Press 9p.

Kassahun, H., Asres, K., Ashenef, A. (2019): In vitro quality evaluation of metformin hydrochloride tablets marketed in Addis Ababa. – Bangladesh Journal of Science and Industrial Research 54(2): 169-76.

Kumari, M.V., Reddy, P.V., Sudhakar, M. (2012): Formulation and evaluation of sustained release matrix tablets of ranolazine. – International Journal of Pharmacy 2(1): 224-229.

Murthy, T.E.G.K., Mukkala, B.V.P., VV, S.B. (2011): Formulation and evaluation of ranolazine extended release tablets: Influence of polymers. – Asian Journal of Pharmaceutics (AJP) 5(3): 5p.

Priya, M.R., Natarajan, R., Rajendran, N.N. (2011): Design and in vitro evaluation of sustained release tablets of ranolazine. – International Journal of Pharmaceutical Sciences and Research 2(4): 922-928.

Pujari, A.S., Gaikwad, N.A., Mane, I.V., Vambhurkar, G.B., Honmane, P.P. (2018): In-Vitro Evaluation of Different Marketed Brands of Paracetamol Tablets Using Quality Control Tests. – Asian Journal of Pharmacy and Technology 8(3): 119-122.

Raslan, M.A., Elshamry, H.G., Elshamry, N.R., Elshamry, H.A., Elshahry, A.H., Elrwely, M.E. (2018): Quality Control Tests for Solid Dosage Forms (review article) Quality Control Tests for Solid Dosage Forms. – Quality Control Review Article 18p.

Remington, J.P. (2006): Remington: the science and practice of pharmacy. – Lippincott Williams & Wilkins 1: 25p.

Thomson, P. (2007): Physician’s desk reference 61st ed. – Tomson PDR, Montvale, NJ 3536p.

Ugale, J.B., Mulgund, S.V. (2015): Development and Validation of UV Spectrophotometric Area under cure method for Quantitative Estimation of Ranolazine in API and Tablet Formulation. – World Journal of Pharmaceutical Research 4(5): 2665-2672.

Vambhurkar, G.B., Jagtap, A.M., Gavade, A.S., Rajput, M.D., Kambale, H.V., Kengar, M.D. (2018): Evaluation of five Different Marketed Brands of Paracetamol Tablets using Quality Control Tests. – Asian Journal of Pharmacy and Technology 8(4): 227-230.

Downloads

Published

2024-08-31

Issue

Section

Articles

How to Cite

IN-VITRO COMPARATIVE QUALITY EVALUATION OF DIFFERENT BRANDS OF RANOLAZINE TABLETS MARKETED IN ANDHRA PRADESH, INDIA. (2024). Quantum Journal of Medical and Health Sciences, 3(3), 64-73. https://qjmhs.com/index.php/qjmhs/article/view/90